Inventor · disambiguated record
Tajesh Jayprakash Patel
Also filed as: PATEL TAJESH · PATEL TAJESH JAYPRAKASH
9 granted patents·5 pending applications·7 citations·filing 2010–2024
78Inventor score
Top patents by PatentIndex Score
14 records- 0191US11708366B2Heteroaryl substituted spiropiperidinyl derivatives and pharmaceutical uses thereofNOVARTIS AG·Filed 2021·Granted Jul 25, 2023·2 cites·27 claims
- 0279US2025092042A1Heteroaryl substituted spiropiperidinyl derivatives and pharmaceutical uses thereofNOVARTIS AG·Filed 2024·Application pending·0 cites
- 0377US12157737B2Heteroaryl substituted spiropiperidinyl derivatives and pharmaceutical uses thereofNOVARTIS AG·Filed 2023·Granted Dec 3, 2024·0 cites·16 claims
- 0475US8697739B2Bicyclic acetyl-CoA carboxylase inhibitors and uses thereofBARNES DAVID WENINGER·Filed 2011·Granted Apr 15, 2014·4 cites·23 claims
- 0563US8394858B2Cyclohexane derivatives and uses thereofBARNES DAVID·Filed 2010·Granted Mar 12, 2013·1 cites·30 claims
- 0663US2025034108A1Sodium channel blockersNOVARTIS AG·Filed 2024·Application pending·0 cites
- 0761US11813306B2Cyclic tetramer compounds as proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors for the treatment of metabolic disordersNOVARTIS AG·Filed 2021·Granted Nov 14, 2023·0 cites·20 claims
- 0861US2025115572A1Spirocyclic piperidinyl derivatives as complement factor b inhibitors and uses thereofNOVARTIS AG·Filed 2023·Application pending·0 cites
- 0959US11026993B2Cyclic tetramer compounds as proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors for the treatment of metabolic disordersNOVARTIS AG·Filed 2019·Granted Jun 8, 2021·0 cites·33 claims
- 1052US12209144B2Cyclic peptides as proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors for the treatment of metabolic disordersNOVARTIS AG·Filed 2019·Granted Jan 28, 2025·0 cites·1 claims
- 1148US9789118B2Bicyclic acetyl-CoA carboxylase inhibitors and uses thereofBARNES DAVID WENINGER·Filed 2014·Granted Oct 17, 2017·0 cites·20 claims
- 1246US2023089867A1Cyclic pentamer compounds as proprotein convertase subtilisin/kexin type 9 (pcsk9) inhibitors for the treatment of metabolic disorderNOVARTIS AG·Filed 2019·Application pending·0 cites
- 1339US9255093B2Polycyclic HERG activatorsBEBERNITZ GREGORY RAYMOND·Filed 2015·Granted Feb 9, 2016·0 cites·16 claims
- 1439US2016108025A1Polycyclic herg activatorsBEBERNITZ GREGORY RAYMOND·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →